Open-trial on the acute treatment of migraine using the Cefaly device
Acute treatment of Migraine using the Cefaly device
Sponsor: Cefaly Technologies
Enrolling: Male and Female Patients
Study Length: 1 Days
Clinic Visits: 1
IRB Number: AAAO9752
Contact: Denise Chou: 212.305.3937 / cc3825@columbia.edu
Additional Study Information: This study plans to learn more about a device called the Cefaly and if it is effective for treating migraine attacks. This device is approved by the Food and Drug Administration (FDA) for the prevention of episodic migraines, but clinical data has not yet been collected on its effectiveness in treating migraine attacks. The Cefaly device works by generating electrical impulses that stimulate certain nerves associated with migraines. A self-adhesive electrode is placed on the forehead. The Cefaly device is worn like a pair of spectacles, and once in position it connects to the electrode. When the button is pressed, the 60-minute course of treatment is delivered automatically. Participation in this study will last 1 hour in the clinic, followed by a brief phone call one hour after participation.
This study is closed
Investigator
Denise Chou, MD
Do You Qualify?
Have you been diagnosed with episodic or chronic migraine? Yes No
Have you received treatment with onabotulinum toxin (e.g. Botox, Dysport, Xeomin) to the head in the last four months? Yes No
Do you have an implanted metal or electrical device in your head? Yes No
Do you have a cardiac pacemaker or defibrillator? Yes No
Are your headaches only temporal or occipital headaches? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder




For more information, please contact:
Denise Chou
cc3825@columbia.edu
212.305.3937